help_outline
Skip to main content
Print This Page
Text Size
Scroll To Top
Add Me To Your Mailing List
Member Login
My Shopping Cart
Shopping Cart
cancel
Share This Page
Share this page on Facebook
Share this page on Linkedin
Share this page on Twitter
Home
About
Who We Are
Mission and Vision
Become a Member
Leadership
Committees
Storefront
Events
Past Events
Upcoming Events
Int'l. Palladium Medal
Othmer Gold Medal Award
Winthrop-Sears Award
Scholarship
Member Forums
Join
Contact
Home
Events
Title: “Private Equity Strategies: A Fireside Chat with John Televantos”
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Events
- Event View
This is the "Event Detail" view, showing all available information for this event. If the event has passed, click the "Event Report" button to read a report and view photos that were uploaded.
Return to Grid View
Show Search
Today
Title: “Private Equity Strategies: A Fireside Chat with John Televantos”
Speaker: John Televantos, Partner, Arsenal Capital
Private equity firms have been very active buyers and sellers of chemical companies since 1998. Arsenal Capital Partners is a specialized private equity firm that invests in the U.S. lower middle market with a narrow and deep focus in two sectors, Specialty Industrials & Healthcare. Dr. Televantos serves as co-head of the specialty industrial practice and has been involved in more than 100 deals during his career at Arsenal. Its philosophy is to partner with talented management teams, provide them with access to world-class operating resources and patient capital, and develop positive, open and constructive relationships that foster long-term value creation.
Peter Young, President of Young & Partners, the chemicals and life science investment bank and of Societe de Chimie Industrielle, will interview John, and will delve into the his personal history, his firm’s track record and investing philosophy, and perspectives on the industry.
About our Speaker:
John Televantos is a Partner at Arsenal Capital Partners, a middle market private equity firm focused on the specialty industrial, healthcare and specialty financial service sectors. Before joining Arsenal in 2006, Dr. Televantos was President of Aqualon Company, owned by Hercules, Inc.; President and Founder of Helios Chemical Company; and Chief Executive Officer for Foamex International. He also had a very successful careers at Union Carbide and Arco Chemical where he led teams that invented key processes for the manufacture of Methyl Chloride and Siloxane polymers and polyols.
At Arsenal Capital, Dr. Televantos serves as co-head of the specialty industrial practice. During his 12 year tenure, he has led or was part of nearly 100 acquisitions in the Chemicals and Specialty Materials space. He was also a leader in several very successful exits where Arsenal built up companies to a much larger scale like Royal Adhesives, Chromaflo, Novolyte Technologies, IDQ, Genovique, Flowchem, among others. In addition to serving on the boards of several Arsenal owned companies, he is lead director on the board of Balchem Corporation (BCPC).
John holds BS and PhD degrees in chemical engineering from Imperial College, London.
When:
Wednesday, September 20, 2017, 11:30 AM until 2:00 PM
Where:
The Yale Club
Directions
50 Vanderbilt Ave
New York, NY 10017
(212) 716-2100
Additional Info:
Event Contact(s):
Danielle J Fraser
203-763-9255 (p)
Category:
Monthly Luncheon
Registration is required
Payment In Full In Advance Only
Cancellation Policy:
Capacity:
0
Available Slots:
0
Filled
Guest of Member
$85.00
Member
$60.00
Non-Member
$85.00
Add to my Calendar
What is this?